4914
Takasago International Corporation
2026/01/16
Takasago International Corporation applied for the tender offer for 420,534 shares of Hisamitsu Pharmaceutical Co., Inc. at 6,082 yen per share, totaling 2,557 million yen, and expects to record an extraordinary profit of 2,408 million yen in the fiscal year ending March 2026.
